Literature DB >> 15308991

Participation versus education: the GISSI story and beyond.

Luigi Tavazzi1, Aldo P Maggioni, Gianni Tognoni.   

Abstract

Approximately 20 years ago, the Italian cardiology community realized the scientific importance and the potential impact on clinical practice of the new concept of evidence-based medicine and launched (without funds) a national megatrial, the Gruppo Italiano por lo Studio della Streptochinasi nell'Infarto Miocardico (GISSI) study. In the following 20 years, 4 GISSI trials have been carried out, and a fifth is underway. The conceptual process that followed this experience shaped the role of the medico-scientific society that sponsored these trials as an active player in research, with the public health as the common target. This process of getting together was founded on the basic principle that active participation can be much more effective and rewarding than education (a passive process). Accordingly, further studies were undertaken dealing with clinical epidemiology, observational outcome research introduced complementarily to develop lines of clinical investigation along 2 mainstreams: ischemic heart disease and heart failure. The original decision to directly sponsor countrywide research projects in critical and relevant areas of care had broader implications not only for the role of scientific societies, but more generally for the nurture of independent research, which is today widely recognized to be at risk. The articulation among experimental, observational, and evaluative protocols in which all caring physicians are allowed to be producers and authors and not simply users of knowledge can favor a cultural continuity that minimizes the risk of parallelisms and gaps between research and care.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15308991     DOI: 10.1016/j.ahj.2004.02.015

Source DB:  PubMed          Journal:  Am Heart J        ISSN: 0002-8703            Impact factor:   4.749


  6 in total

Review 1.  Efficient design of clinical trials and epidemiological research: is it possible?

Authors:  Michael S Lauer; David Gordon; Gina Wei; Gail Pearson
Journal:  Nat Rev Cardiol       Date:  2017-04-27       Impact factor: 32.419

2.  From hot hands to declining effects: the risks of small numbers.

Authors:  Michael S Lauer
Journal:  J Am Coll Cardiol       Date:  2012-07-03       Impact factor: 24.094

3.  Commentary on Vickers.

Authors:  Michael S Lauer
Journal:  Clin Trials       Date:  2014-12       Impact factor: 2.486

4.  Building the case for novel clinical trials in pulmonary arterial hypertension.

Authors:  John J Ryan; Jonathan D Rich; Bradley A Maron
Journal:  Circ Cardiovasc Qual Outcomes       Date:  2015-01

5.  Embedding patient- and public health-oriented research in a national health service: the GISSI experience.

Authors:  Gianni Tognoni; Maria Grazia Franzosi; Silvio Garattini
Journal:  J R Soc Med       Date:  2019-05       Impact factor: 5.344

6.  Does language matter? A case study of epidemiological and public health journals, databases and professional education in French, German and Italian.

Authors:  Iacopo Baussano; Patrick Brzoska; Ugo Fedeli; Claudia Larouche; Oliver Razum; Isaac C-H Fung
Journal:  Emerg Themes Epidemiol       Date:  2008-09-30
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.